Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Amarin Corp. ADR | 2 | 1 | 0 | 0 | €0.73 | - | - |
| Immunogen Inc. | 4 | 0 | 0 | 0 | €28.97 | - | - |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | €104.25 | - | - |
| Horizon Pharma plc | 2 | 0 | 0 | 0 | €110.40 | - | - |
| Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | €5.80 | - | - |
| Novocure Ltd | 1 | 1 | 0 | 0 | €17.10 | - | - |
| Grifols S.A. | 1 | 0 | 0 | 0 | €8.97 | - | - |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.58 | - | - |
| Omeros Corp. | 2 | 4 | 0 | 0 | €5.03 | - | - |
| Vericel Corp. | 1 | 0 | 0 | 0 | €48.60 | - | - |
| Puma Biotechnology Inc. | 1 | 0 | 1 | 0 | €3.45 | - | - |
| UCB S.A. | 1 | 0 | 0 | 0 | €144.90 | - | - |
| Veracyte Inc. | 1 | 0 | 0 | 0 | €22.00 | - | - |
| Trinity Biotech ADR | 27 | 0 | 3 | 0 | €0.41 | - | - |
| Natural Alternat. | 21 | 1 | 3 | 0 | €5.05 | - | - |
| Cerenis Therapeutics Holding S.A. | 1 | 0 | 0 | 0 | €1.17 | €1.60 | 36.986% |
| Brainstorm Cell | 2 | 0 | 1 | 0 | €0.31 | €1.84 | 496.429% |
| Adaptimmune Therapeutics PLC ADR | 2 | 1 | 2 | 1 | €1.11 | €2.00 | 80.180% |
| Nektar Therapeutics | 4 | 1 | 1 | 0 | €1.28 | €2.40 | 88.088% |
| Rockwell Medical Inc. | 1 | 0 | 0 | 0 | €1.72 | €3.00 | 74.014% |
| Aclaris Therapeutics Inc | 1 | 0 | 0 | 0 | €1.27 | €3.00 | 136.407% |
| ProQR Therapeutics N.V. | 8 | 2 | 0 | 0 | €1.73 | €3.03 | 75.399% |
| Akebia Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.35 | €3.64 | 169.556% |
| Xeris Biopharma Holdings Inc. | 6 | 0 | 0 | 0 | €2.23 | €4.39 | 97.096% |
| Heron Therapeutics Inc. | 12 | 1 | 0 | 0 | €2.92 | €4.60 | 57.676% |